BioCorRx Inc. (BICX) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
2390 EAST ORANGEWOOD AVENUE ANAHEIM, CA 92806 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8093 - Specialty Outpatient Facilities, Not Elsewhere Classified (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 69 | 86 | 592 | 2,646 | 280 | ||||
| Cash and cash equivalent | 69 | 86 | 592 | 2,646 | 280 | ||||
| Receivables | 1 | ||||||||
| Prepaid expense | 45 | 83 | 85 | 157 | 213 | 31 | |||
| Other undisclosed current assets | 141 | 166 | 58 | 225 | 187 | 8 | |||
| Total current assets: | 187 | 317 | 228 | 975 | 3,047 | 319 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 97 | 270 | 385 | 490 | 459 | ✕ | |||
| Property, plant and equipment | 51 | 77 | 103 | 129 | 148 | 44 | |||
| Long-term investments and receivables | 45 | 45 | 45 | 42 | 13 | ||||
| Long-term investments | 45 | 45 | 45 | 42 | 13 | ||||
| Intangible assets, net (including goodwill) | 9 | 10 | 11 | 177 | 14 | 15 | |||
| Intangible assets, net (excluding goodwill) | 9 | 10 | 11 | 177 | 14 | 15 | |||
| Deferred costs | 48 | ||||||||
| Other undisclosed noncurrent assets | 45 | 48 | 13 | 224 | 236 | ||||
| Total noncurrent assets: | 202 | 450 | 592 | 852 | 887 | 309 | |||
| TOTAL ASSETS: | 389 | 767 | 820 | 1,827 | 3,933 | 628 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 4,649 | 3,908 | 3,189 | 2,490 | 2,027 | 1,555 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | 1,154 | 1,138 | 1,138 | 898 | ||
| Accounts payable | 2,473 | 2,013 | 1,777 | 1,181 | 709 | 656 | |||
| Accrued liabilities | 1,268 | 1,207 | |||||||
| Other undisclosed accounts payable and accrued liabilities | 907 | 688 | 258 | 171 | 180 | 0 | |||
| Deferred revenue | 33 | 35 | 63 | 135 | ✕ | ||||
| Debt | 607 | 298 | 221 | (55) | 673 | ||||
| Accrued reclamation costs | 43 | ||||||||
| Due to related parties | ✕ | ✕ | 991 | 391 | 32 | ||||
| Other undisclosed current liabilities | 1,132 | 134 | 941 | 499 | 53 | 3,868 | |||
| Total current liabilities: | 6,431 | 5,364 | 4,386 | 3,052 | 2,551 | 6,127 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 74 | 435 | 428 | ||||||
| Long-term debt, excluding current maturities | 74 | ||||||||
| Liabilities, other than long-term debt, including: | 15 | 185 | 37 | 72 | 103 | 208 | |||
| Deferred revenue | 4 | 4 | 37 | 72 | 103 | ✕ | |||
| Operating lease, liability | 11 | 181 | 435 | 428 | ✕ | ||||
| Other undisclosed liabilities, other than long-term debt | 208 | ||||||||
| Other undisclosed noncurrent liabilities | 3,895 | 3,345 | 3,358 | 2,477 | 1,910 | ||||
| Total noncurrent liabilities: | 3,910 | 3,605 | 3,395 | 2,985 | 2,441 | 208 | |||
| Total liabilities: | 10,341 | 8,968 | 7,781 | 6,037 | 4,992 | 6,335 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (9,824) | (8,202) | (6,844) | (4,210) | (1,059) | (5,706) | |||
| Preferred stock | 16 | ||||||||
| Common stock | 9 | 8 | 7 | 5 | 5 | 3 | |||
| Common stock, value, subscriptions | 100 | 100 | 100 | 100 | 100 | 100 | |||
| Additional paid in capital | 68,149 | 66,130 | 62,995 | 60,466 | 60,111 | 49,418 | |||
| Accumulated deficit | (78,103) | (74,336) | (69,967) | (64,688) | (61,216) | (55,176) | |||
| Other undisclosed equity, attributable to parent | 22 | (104) | 22 | (94) | (60) | (67) | |||
| Equity, attributable to noncontrolling interest | (129) | (118) | (115) | (81) | |||||
| Other undisclosed equity | 231 | 162 | 72 | ||||||
| Total equity: | (9,953) | (8,202) | (6,961) | (4,095) | (978) | (5,634) | |||
| Other undisclosed liabilities and equity | (115) | (81) | (72) | ||||||
| TOTAL LIABILITIES AND EQUITY: | 389 | 767 | 820 | 1,827 | 3,933 | 628 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 89 | 214 | 48 | 123 | 240 | 377 | ||
| Other income | 139 | |||||||
| Cost of revenue | (36) | (19) | (6) | (96) | (82) | (171) | ||
| Cost of product and service sold | (19) | |||||||
| Gross profit: | 53 | 195 | 42 | 27 | 159 | 206 | ||
| Operating expenses | (3,877) | (4,912) | (5,558) | (7,615) | (5,802) | (5,003) | ||
| Other undisclosed operating income | 36 | 19 | 6 | 96 | 82 | 171 | ||
| Operating loss: | (3,788) | (4,698) | (5,510) | (7,492) | (5,561) | (4,626) | ||
| Nonoperating income (expense) | 17 | 321 | 299 | 3,985 | (487) | (1,958) | ||
| Other nonoperating income | 5 | 321 | ||||||
| Interest and debt expense | (34) | 133 | (28) | (26) | (8) | 1 | ||
| Loss from continuing operations before equity method investments, income taxes: | (3,805) | (4,243) | (5,239) | (3,533) | (6,056) | (6,584) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 34 | (133) | ||||||
| Loss from continuing operations before income taxes: | (3,770) | (4,377) | (5,239) | (3,533) | (6,056) | (6,584) | ||
| Income tax expense | (66) | |||||||
| Other undisclosed income from continuing operations | 3,632 | |||||||
| Income (loss) from continuing operations: | (3,770) | (4,377) | (5,239) | 34 | (6,056) | (6,584) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (5,239) | 34 | (6,056) | (6,584) | |
| Other undisclosed net income | 8,754 | |||||||
| Net income (loss): | (3,770) | 4,377 | (5,239) | 34 | (6,056) | (6,584) | ||
| Net income attributable to noncontrolling interest | 5,278 | 3,472 | 6,040 | 6,512 | ||||
| Other undisclosed net loss attributable to parent | (8,754) | (5,250) | (7,013) | (6,032) | (6,513) | |||
| Net loss attributable to parent: | (3,770) | (4,377) | (5,211) | (3,507) | (6,048) | (6,584) | ||
| Preferred stock dividends and other adjustments | 70 | |||||||
| Other undisclosed net income available to common stockholders, basic | ||||||||
| Net loss available to common stockholders, diluted: | (3,770) | (4,377) | (5,141) | (3,507) | (6,048) | (6,584) | ||
Comprehensive Income ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (3,770) | 4,377 | (5,239) | 34 | (6,056) | (6,584) | ||
| Comprehensive income (loss): | (3,770) | 4,377 | (5,239) | 34 | (6,056) | (6,584) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 5,278 | 3,472 | 6,040 | 6,512 | ||||
| Comprehensive income (loss), net of tax, attributable to parent: | (3,770) | 4,377 | 40 | 3,507 | (17) | (72) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.